Tentative inhaled steroids is worse for lung patients
According to a new study, patients with lung disease suffered more complications if they tried doing without inhaled steroids. Researchers in Texas studied a group of 200 patients with chronic obstructive pulmonary disease (COPD).// All received a high dose of inhaled steroids, to manage their condition, for a period of four months. After this time, they either continued the steroids or received...Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market. // The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange. The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it...Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
Aurobindo Pharma today said it has recieved a tentative New Drug Approval from USFDA for its fixed dose combination product used for treating HIV-1 infection//. The new drug approval is for fixed dose combination drug product containing Lamivudine, Zidovudine, Nevirapine tablets used in the treatment of HIV-1 infection, the company informed the Bombay Stock Exchange. The t...Lupin Gets Tentative Nod from FDA for Antidepressant Drug
Leading pharmaceutical company Lupin Ltd has received tentative approval from the US Food and Drug Administration (FDA) for its generic drug Sertraline Hydrochloride for// treatment of major depressive disorder. Mumbai based Lupin's Sertraline Hydrochloride tablets will be the AB-rated generic equivalent of Pfizer's Zoloft tablets of 25mg, 50mg and 100mg dosage. "The compa...Mylan Announces Tentative FDA Approval for Its ANDA
Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Paroxetine Hydrochloride Extended-release Tablets, 12.5 mg and 25 mg. Mylan's ANDA is eligible to receive final approval on June 29, 2007, concurrent with the expiration of the ped...